The comparison of the tumor samples with distinct TNM stages revealed that PLOD3 was increased in the advanced TNM stages in both TCGA and CPTAC cohorts (Figures 3(a) and 3(b), P value <0.01). The gene discussed is PLOD3; the disease is neoplasm.